FLXN

BUYOUT PROBABILITY ON FLEXION THERAPEUTICS LESSENED, TAKE PROFITS AND EXIT $FLXN

This post was just published on ZYX Buy Change Alert.   125 of our portfolio companies have been bought out.  Long-time subscribers to The Arora Report have profited handsomely from buyouts. FLXN has been a buyout candidate.  However the probability of a buyout has lessened based on recent developments. FLXN is long from an

Read More

TAKE PARTIAL PROFITS ON FLEXION THERAPEUTICS $FLXN

This post was just published on ZYX Buy Change Alert.  FLXN is long from 18.75.  The stock is trading at $23.19 as of this writing.  The original thesis remains intact. The new target zone is $38 to $44.  However, there are many very near term risks that could cause the stock to

Read More

A SPECIAL NOTE FOR NEW SUBSCRIBERS, LONG-TERM INVESTMENTS AND/OR SHORT-TERM TRADES, AN IMPORTANT TIP $FLXN $XBI $IBB $LABU $LABD $SPY

This post was just published on ZYX Buy Change Alert.  Our subscribers have a wide range of interests. Some focus only on long-term investments, others focus only on short-term trades.  Some do both. If your focus is on long-term investments, there is no need to be nimble.  There is no need to

Read More

PLAN ON FLEXION THERAPEUTICS, QUICK DENIAL MAY MEAN HIGHER POTENTIAL OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert. A quick denial of a potential deal is not typical, as has happened in the case of FLXN.  One hypothetical explanation is that  the deal is potentially in the works but a quick run-up in the stock makes the deal difficult.  Hypothetically,

Read More

TAKE PROFITS ON FLEXION THERAPEUTICS RIGHT HERE AROUND $25.88, IF FILLED $FLXN $SYN

This post was just published on ZYX Buy Change Alert.   You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable performance

Read More

FLEXION THERAPEUTICS: CHANGING THE BUY ZONE TO $20 TO $21.15, SNY DENIES THE DEAL $FLXN $SYN

This post was just published on ZYX Buy Change Alert. More later You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable

Read More

INTELLIGENCE: A NEW IDEA ON FLEXION THERAPEUTICS, RUMORS OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide intelligence

Read More

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence